LEF1

LEF1

Target · Transcription factor

LEF1 Lymphoid enhancer-binding factor 1 · TCF1alpha

LEF1 (lymphoid enhancer binding factor 1; also TCF1ALPHA, TCF10 and TCF7L3) is a nuclear transcription factor of the TCF/LEF family. It acts in Wnt signalling and regulates gene promoters and enhancers, including the T-cell receptor-alpha enhancer. Browse Assay Genie's current range of LEF1 research reagents below, or read on for the biology behind the target.

Nuclear proteinTCF/LEF transcription factorWnt pathway component
399 aa
Protein length
~44 kDa
Molecular weight
4q25
Gene locus
TCF/LEF
Protein family
Target information

What is LEF1 (lymphoid enhancer binding factor 1)?

LEF1 is a transcription factor that regulates target genes by binding DNA at functionally important sites. It can bind a key site in the T-cell receptor-alpha enhancer, where it confers maximal enhancer activity. UniProt annotation also describes LEF1 as transcriptionally activating the fibronectin promoter. In contrast, it binds to and represses transcription from the E-cadherin promoter, and it does so independently of CTNNB1. This dual behaviour places LEF1 in the control of cell adhesion and motility: it is involved in reducing cellular aggregation and increasing cell migration of pancreatic cancer cells.

The LEF1 gene encodes a protein that localises to the nucleus and belongs to the TCF/LEF family. Members of this family share homology with the high mobility group protein-1. HGNC places the gene in the TCF/LEF transcription factor family and the Wnt enhanceosome complex group. Alternative splicing of the gene results in multiple transcript variants. Mouse and rat both carry a Lef1 ortholog, so the protein can be studied in common rodent models.

LEF1 is involved in the Wnt signalling pathway, and it may function in hair cell differentiation and follicle morphogenesis. Mutations in the LEF1 gene have been found in somatic sebaceous tumours, and the gene has also been linked to other cancers, including androgen-independent prostate cancer. The aliases TCF1ALPHA, TCF10 and TCF7L3 reflect its place among the TCF transcription factors and may appear in older literature.

Wnt signalling research

LEF1 is a transcription factor involved in the Wnt signalling pathway and a member of the Wnt enhanceosome complex group.

Cancer biology

The LEF1 gene is linked to androgen-independent prostate cancer and other cancers, and mutations occur in somatic sebaceous tumours.

Cell adhesion and migration

LEF1 represses the E-cadherin promoter and activates the fibronectin promoter, affecting aggregation and migration of pancreatic cancer cells.

T-cell gene regulation

LEF1 binds a functionally important site in the T-cell receptor-alpha enhancer, conferring maximal enhancer activity.

Background

LEF1 frequently asked questions

What does LEF1 do?

LEF1 is a nuclear transcription factor. It binds the T-cell receptor-alpha enhancer, activates the fibronectin promoter and represses the E-cadherin promoter independently of CTNNB1. It is involved in Wnt signalling and may function in hair cell differentiation and follicle morphogenesis.

What other names and isoforms does LEF1 have?

LEF1 is also known as TCF1ALPHA, TCF10 and TCF7L3, and its full name is lymphoid enhancer binding factor 1. Alternative splicing of the LEF1 gene produces multiple transcript variants. Check the datasheet of any product for its validated reactivity.

Is LEF1 linked to disease or conserved in other species?

Mutations in LEF1 have been found in somatic sebaceous tumours, and the gene is linked to other cancers, including androgen-independent prostate cancer. Mouse and rat each have a Lef1 ortholog. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other targets with related names and pathway context that have products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UJU2; product specifications from Assay Genie datasheets.

LEF1 Product listing